Product Pathways - PI3K / Akt Signaling
SignalStain® Akt Pathway IHC Sampler Kit #8107
|8107S||1 Kit (4 x 40 µl)||---||In Stock||---|
|8107||carrier free and custom formulation / quantity||email request|
Already purchased this product? Write a Review.
|Kit Includes||Quantity||Antigen Retrieval / Diluent||Isotype|
|Phospho-Akt (Ser473) (D9E) XP® Rabbit mAb #4060||40 µl||Citrate / SignalStain® Antibody Diluent #8112||Rabbit IgG|
|Phospho-S6 Ribosomal Protein (Ser235/236) (D57.2.2E) XP® Rabbit mAb #4858||40 µl||Citrate / SignalStain® Antibody Diluent #8112||Rabbit IgG|
|Akt (pan) (C67E7) Rabbit mAb #4691||40 µl||Citrate / SignalStain® Antibody Diluent #8112||Rabbit IgG|
|PTEN (D4.3) XP® Rabbit mAb #9188||40 µl||Citrate / SignalStain® Antibody Diluent #8112||Rabbit IgG|
|*SignalStain® Antibody Diluent #8112||25 ml|
|†SignalSlide® Akt Family IHC Controls #8115||1 Pack|
*SignalStain® Antibody Diluent is supplied as a working solution and should be stored at 4ºC (packaged separately).
†Control slides should be stored at 4ºC (packaged separately).
Custom Ordering Details
The control slides that accompany this kit are cut freshly upon ordering. Please allow three to five days for your order to be processed and shipped.
The SignalStain® Akt Pathway IHC Sampler Kit from Cell Signaling Technology allows the researcher to examine paraffin-embedded tissues or cells with antibodies directed against proteins involved in Akt signaling. Multiple approaches are used to validate each antibody for use in immunohistochemical assays. Also included in the kit are control slides that can be used to verify the performance of each antibody and a primary antibody diluent. Please see the above table for the recommended antibody diluent for each kit antibody.
Specificity / Sensitivity
Each antibody in the SignalStain® Akt Pathway IHC Sampler Kit detects endogenous levels of its target protein and does not cross-react with related proteins.
Source / Purification
Monoclonal antibody is produced by immunizing animals with synthetic phosphopeptides corresponding to residues surrounding the phosphorylation site(s) of interest, and synthetic peptides corresponding to the carboxy-terminal sequence of mouse Akt or from the carboxy-terminal sequence of human PTEN.
Immunohistochemical analysis of paraffin-embedded LNCaP cell pellets, either untreated (left) or LY294002-treated (middle) or NIH/3T3 cell pellets (right), using Phospho-Akt (Ser473) (D9E) Rabbit mAb, Akt (pan) (C67E7) Rabbit mAb, PTEN (D4.3) Rabbit mAb and Phospho-S6 Ribosomal Protein (Ser235/236) (D57.2.2E) Rabbit mAb. Cell pellets are provided in the SignalSlide® Akt Family IHC Controls.
The protein kinase Akt (also called PKB or Rac) is activated by insulin and growth and survival factors to function in a wortmannin-sensitive pathway involving PI3 kinase (1,2). Akt is activated by phospholipid binding and activation loop phosphorylation at Thr308 by PDK1 (3) and by carboxy terminal phosphorylation at Ser473 by the mTORC2 complex composed of mammalian target of rapamycin (mTOR) in a complex with rictor and Sin1 (4,5). Akt signaling is negatively regulated via the PTEN phosphatase (6).
Akt’s several functions include inhibition of apoptosis (7-9), regulation of glycogen synthesis via GSK-3 (10), and promotion of the cell cycle (11). Akt also regulates protein synthesis by phosphorylating mTOR in a rapamycin-sensitive complex containing raptor (mTORC1) (12). Akt also effects mTOR activity via phosphorylation and inhibition of PRAS40 (40 kDa, proline-rich protein), which binds to raptor in the mTORC1 complex and inhibits mTOR activity (13). Phosphorylation of PRAS40 by Akt at Thr246 relieves PRAS40 inhibition of mTORC1 (14), allowing protein synthesis to occur. Active of mTORC1 signals to p70 S6 kinase, which in turn phosphorylates S6 ribosomal protein. Phosphorylation of S6 ribosomal protein correlates with an increase in translation of a subset of mRNA transcripts that encode ribosomal proteins, translation elongation factors as well as regulators of cell cycle progression (15). Important S6 ribosomal protein phosphorylation sites include Ser235, Ser236, Ser240 and Ser244 within a small carboxy-terminal region (16).
- Franke, T.F. et al. (1997) Cell 88, 435-7.
- Franke, T.F. et al. (1995) Cell 81, 727-36.
- Alessi, D.R. et al. (1996) EMBO J 15, 6541-51.
- Sarbassov, D.D. et al. (2005) Science 307, 1098-101.
- Jacinto, E. et al. (2006) Cell 127, 125-37.
- Cantley, L.C. and Neel, B.G. (1999) Proc Natl Acad Sci USA 96, 4240-5.
- Cardone, M.H. et al. (1998) Science 282, 1318-21.
- Brunet, A. et al. (1999) Cell 96, 857-68.
- Zimmermann, S. and Moelling, K. (1999) Science 286, 1741-4.
- Cross, D.A. et al. (1995) Nature 378, 785-9.
- Zhou, B.P. et al. (2001) Nat Cell Biol 3, 245-52.
- Navé, B.T. et al. (1999) Biochem J 344 Pt 2, 427-31.
- Vander Haar, E. et al. (2007) Nat Cell Biol 9, 316-23.
- Sancak, Y. et al. (2007) Mol Cell 25, 903-15.
- Peterson, R.T. and Schreiber, S.L. (1998) Curr Biol 8, R248-50.
- Ferrari, S. et al. (1991) J Biol Chem 266, 22770-5.
Have you published research involving the use of our products? If so we'd love to hear about it. Please let us know!
* Product-specific protocol.
- 3900 Rabbit (DA1E) mAb IgG XP® Isotype Control
- 4060 Phospho-Akt (Ser473) (D9E) XP® Rabbit mAb
- 4858 Phospho-S6 Ribosomal Protein (Ser235/236) (D57.2.2E) XP® Rabbit mAb
- 4691 Akt (pan) (C67E7) Rabbit mAb
- 9188 PTEN (D4.3) XP® Rabbit mAb
- 8115 SignalSlide® Akt Family IHC Controls
- 8112 SignalStain® Antibody Diluent
- 1140 Phospho-Akt (Ser473) Blocking Peptide
- 1220 Phospho-S6 Ribosomal Protein (Ser235/236) Blocking Peptide
- 1085 Akt (pan) Blocking Peptide
- 1250 PTEN Blocking Peptide
For Research Use Only. Not For Use In Diagnostic Procedures.
SignalStain® is a trademark of Cell Signaling Technology, Inc.
Cell Signaling Technology® is a trademark of Cell Signaling Technology, Inc.
Select rabbit monoclonal antibodies are developed, validated, and produced at CST using in part technology under license (granting certain rights including those under U.S. Patents No. 5,675,063 and in some instances 7,429,487) from Epitomics, Inc.